Cochlear Future Growth
Future criteria checks 2/6
Cochlear is forecast to grow earnings and revenue by 11.7% and 8.1% per annum respectively. EPS is expected to grow by 11.7% per annum. Return on equity is forecast to be 25% in 3 years.
Key information
11.7%
Earnings growth rate
11.7%
EPS growth rate
Medical Equipment earnings growth | 17.1% |
Revenue growth rate | 8.1% |
Future return on equity | 25.0% |
Analyst coverage | Good |
Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 2,921 | 531 | 486 | 600 | 13 |
6/30/2026 | 2,676 | 467 | 409 | 521 | 14 |
6/30/2025 | 2,463 | 422 | 408 | 522 | 14 |
6/30/2024 | 2,236 | 357 | 299 | 389 | N/A |
3/31/2024 | 2,193 | 354 | 317 | 410 | N/A |
12/31/2023 | 2,149 | 350 | 335 | 430 | N/A |
9/30/2023 | 2,043 | 326 | 301 | 396 | N/A |
6/30/2023 | 1,936 | 301 | 267 | 362 | N/A |
3/31/2023 | 1,824 | 281 | 263 | 352 | N/A |
12/31/2022 | 1,713 | 261 | 259 | 341 | N/A |
9/30/2022 | 1,681 | 275 | 279 | 359 | N/A |
6/30/2022 | 1,648 | 289 | 299 | 377 | N/A |
3/31/2022 | 1,612 | 273 | 266 | 340 | N/A |
12/31/2021 | 1,575 | 257 | 233 | 304 | N/A |
9/30/2021 | 1,536 | 291 | 216 | 285 | N/A |
6/30/2021 | 1,498 | 324 | 199 | 265 | N/A |
3/31/2021 | 1,403 | 82 | -52 | 34 | N/A |
12/31/2020 | 1,308 | -160 | -302 | -198 | N/A |
9/30/2020 | 1,314 | -199 | -295 | -178 | N/A |
6/30/2020 | 1,321 | -238 | -288 | -158 | N/A |
3/31/2020 | 1,400 | 34 | -80 | 50 | N/A |
12/31/2019 | 1,479 | 306 | 128 | 259 | N/A |
9/30/2019 | 1,453 | 291 | 155 | 277 | N/A |
6/30/2019 | 1,427 | 277 | 181 | 296 | N/A |
3/31/2019 | 1,422 | 270 | 217 | 313 | N/A |
12/31/2018 | 1,418 | 264 | 252 | 330 | N/A |
9/30/2018 | 1,391 | 255 | 230 | 294 | N/A |
6/30/2018 | 1,364 | 246 | 208 | 258 | N/A |
3/31/2018 | 1,329 | 234 | N/A | 254 | N/A |
12/31/2017 | 1,294 | 223 | N/A | 250 | N/A |
9/30/2017 | 1,274 | 223 | N/A | 255 | N/A |
6/30/2017 | 1,254 | 224 | N/A | 260 | N/A |
3/31/2017 | 1,218 | 215 | N/A | 237 | N/A |
12/31/2016 | 1,182 | 206 | N/A | 214 | N/A |
9/30/2016 | 1,156 | 198 | N/A | 199 | N/A |
6/30/2016 | 1,131 | 189 | N/A | 185 | N/A |
3/31/2016 | 1,088 | 179 | N/A | 179 | N/A |
12/31/2015 | 1,045 | 168 | N/A | 172 | N/A |
9/30/2015 | 986 | 157 | N/A | 181 | N/A |
6/30/2015 | 926 | 146 | N/A | 189 | N/A |
3/31/2015 | 899 | 145 | N/A | 178 | N/A |
12/31/2014 | 872 | 144 | N/A | 168 | N/A |
9/30/2014 | 839 | 119 | N/A | 140 | N/A |
6/30/2014 | 805 | 94 | N/A | 111 | N/A |
3/31/2014 | 769 | 85 | N/A | 93 | N/A |
12/31/2013 | 732 | 76 | N/A | 75 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CHEO.Y's forecast earnings growth (11.7% per year) is above the savings rate (2.6%).
Earnings vs Market: CHEO.Y's earnings (11.7% per year) are forecast to grow slower than the US market (15.3% per year).
High Growth Earnings: CHEO.Y's earnings are forecast to grow, but not significantly.
Revenue vs Market: CHEO.Y's revenue (8.1% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: CHEO.Y's revenue (8.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CHEO.Y's Return on Equity is forecast to be high in 3 years time (25%)